Molecular Targeting Technologies, Inc. and Molecular Theranostics Center of Singapore Receive HSA Approval for Clinical Trial Authorization for EBTATE® in Nasopharyngeal Cancer

[ad_1] Molecular Targeting Technologies, Inc. and Molecular Theranostics …  WV News [ad_2] Source link

Takeda and HUTCHMED Announce Marketing Authorization Application of Fruquintinib for Previously Treated Metastatic Colorectal Cancer Validated by the European Medicines Agency

[ad_1] We recognize you are attempting to access this website from a country belonging to the European Economic Area (EEA) including the EU which enforces the General Data Protection Regulation…

McCormick Engineering Events | Monthly Seminar on Physical Genomics – Abnormal Mechanics in Brain Tumors: Implications for Immunotherapy

[ad_1] Events To filter event listings, choose your filter options below and click submit at the bottom of the form. eg. John Smith, company day — comma separated …

Fusion Pharmaceuticals Announces First Patient Dosed in Phase 1 Study of FPI-2059, a Targeted Alpha Therapy (TAT) for the Treatment of Solid Tumors Expressing NTSR1

[ad_1] HAMILTON, ON and BOSTON, March 20, 2023 /PRNewswire/ — Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced that the first patient…

Democratic Rep. Joaquin Castro undergoes surgery to remove tumors

[ad_1] Democratic Rep. Joaquin Castro of Texas said Monday that he “successfully” underwent surgery to remove tumors discovered last summer in the lining of his gastrointestinal tract. Castro, 48, said…